3rd Quarter - Report

AMERICAN SOCIETY OF ANESTHESIOLOGISTS for AMERICAN SOCIETY OF ANESTHESIOLOGISTS

Firm
Client
Income
—
Expenses
$300,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

Veterans Affairs Advance Practice Registered Nurses - "VHA Nursing Handbook"

LobbyistCovered position, as disclosed
MAUREEN AMOS —
MANUEL BONILLA —
GRANT COUCH —
AMANDA RENEE LEDFORD New —
MICHELLE MATHY —
NORA BAUMEISTER MATUS New House Senior Advisor & House Chief of Staff
SHARON MERRICK —
LISA PEARLSTEIN —

Contacted: Drug Enforcement Administration (DEA); Justice, Dept of (DOJ); Government Accountability Office (GAO); Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Occupational Safety & Health Administration (OSHA); Office of Management & Budget (OMB); Federal Trade Commission (FTC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE

Health Issues HCR

H.R. 1427, Truth in Healthcare Marketing Act of 2013 H.R. 3204, Drug Quality and Security Act H.R. 1173, Palliative Care BillDrug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee PPACA Nondiscrimination language regarding paraprofessionals - repeal DEA Scheduling Propofol Comparative Effectiveness Research HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Risk Evaluation and Mitigation Strategies FDA Safe Use Initiative Pain Management Proposed Federal CME requirements by ONDCP FTC Letters to States regarding Interventional Pain Medicine and Advanced Practice NursesScope of Practice FDA Operating Room Fires State Exchanges pursuant to PPACA FDA SEDASYS FDA Patient Prescriber working group FDA Sedation Initiative Naloxone ICD-10-CM/PCS and proposed delay of implementation date FDA Opioid Labeling FDA Sugammadex Prescription Opioids and Pain Residency Act FDA Workshop on Opioid Conversion Hydrocodone HHS AIDE Action Plan

LobbyistCovered position, as disclosed
MAUREEN AMOS —
MANUEL BONILLA —
GRANT COUCH —
AMANDA RENEE LEDFORD New —
MICHELLE MATHY —
NORA BAUMEISTER MATUS New House Senior Advisor & House Chief of Staff
SHARON MERRICK —
LISA PEARLSTEIN —

Contacted: Drug Enforcement Administration (DEA); Justice, Dept of (DOJ); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Occupational Safety & Health Administration (OSHA); Office of Management & Budget (OMB); Federal Trade Commission (FTC); Defense, Dept of (DOD); Government Accountability Office (GAO); SENATE; Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3204 (113th), H.R. 1173 (113th), H.R. 1427 (113th)

Medicare/Medicaid MMM

H.R. 574, Medicare Physician Payment Innovation Act H.R. 1427, Truth in Healthcare Marketing Act of 2013 H.R. 1331, Electronic Health Records Improvement ActH.R. 2810, Medicare Patient Access and Quality Improvement Act S.1444, Medicare Access to Rural Anesthesiology Act of 2013 H.R. 351, Protecting Seniors' Access to Medicare Act; IPAB S.351, Protecting Seniors' Access to Medicare Act; IPAB Budget Control Act of 2011: P.L. 112-25 Anesthesia Rural Pass Through Reform of the Medicare Sustainable Growth Rate - House Energy & Commerce and Ways & Means proposal Historical Medicare payment undervaluation for anesthesiology services (33% problem) Anesthesia Conversion Factor Perioperative Surgical Home Model Medicare Reform, Payment Issues: Medicare Sustainable Growth Rate repeal Bundled payments CMS Interpretive Guidelines: Hospital Conditions of Participation Related to Anesthesia Services 2014 Medicare Physician Fee Schedule RuleCMS Value-Based purchasing CMS Medicare Data Final Rule CMS Proposed Rule on Sunshine Act CMS Reporting and Returning of Overpayments Conditions of Participation - Anesthesia services, opt-outs, supervision Physician Quality Reporting System, PPACA, Sec. 3007 Quality Modifier implementation President Obama's deficit reduction plans, IPAB cuts Accountable Care Organizations Graduate Medical Education Cuts Medicare Local Coverage Determinations HHS Plan for Retrospective Review of Existing Rules 2011 - Conditions of Participation Value-based modifier - PPACA Debt ceiling- Medicare sequestration E-Prescribing

LobbyistCovered position, as disclosed
MAUREEN AMOS —
MANUEL BONILLA —
GRANT COUCH —
AMANDA RENEE LEDFORD New —
MICHELLE MATHY —
NORA BAUMEISTER MATUS New House Senior Advisor & House Chief of Staff
SHARON MERRICK —
LISA PEARLSTEIN —

Contacted: Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Occupational Safety & Health Administration (OSHA); Drug Enforcement Administration (DEA); Executive Office of the President (EOP); Government Accountability Office (GAO); SENATE; Food & Drug Administration (FDA); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1427 (113th), H.R. 574 (113th), S. 1444 (113th), S. 351 (113th), H.R. 1331 (113th), H.R. 351 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.